Home > PJ > News Feature

Return to PJ Online Home Page The Pharmaceutical Journal Vol 266 No 7142 p451
April 7, 2001

News

Government chooses three routes for evaluating electronic transfer of prescriptions

Background information on the electronic transfer of prescriptions pilots can be found on the Department of Health's website. Jonathan Buisson investigates what the pilot projects will involve and where ETP is heading


Full-scale pilot trials of the electronic transfer of prescriptions (ETP) should be under way in the autumn after the Department of Health announced that three consortia had been chosen on March 29. The consortia contain a mixture of well-known pharmacy and multinational companies and some less well known technology partners.

The Department expects the first pilots to start between March and December, 2001, and to be completed by the end of June, 2002. All three pilots will be subject to an independent evaluation looking at the costs and benefits of ETP, what lessons were learnt from the pilots and how ETP could be rolled out nationally. A final report is expected in December, 2002.

Among the benefits that the Department says might be seen are

  • releasing general practitioners' and pharmacists' time
  • safer prescribing and dispensing
  • collection of additional data on fraud and prescriptions which are not dispensed
  • more efficient processing by the Prescription Pricing Authority

Costs could include increased computing costs and higher risks of fraud.

Each of the three consortia will be evaluating a different model for ETP (see Panel below).

The Sema-led consortium will be looking at the so-called “relay” or “pull” model. Phil Hurst (senior ETP project manager, Boots the Chemists) said that the relay model allowed patients to have complete freedom of choice as to where their prescriptions were dispensed. The pilot would start with a single GP practice and a single pharmacy, but the consortium wanted all community pharmacies in the Peterborough area to join the pilot. A second phase of the pilot would look at the use of ETP in medicines management schemes.

The Pharmacy2u-led consortium is following the “push” or direct transmission to pharmacies model. Alternatively, patients will be able to opt to have their prescriptions dispensed through Pharmacy2u's internet operation with the dispensed medicines delivered directly to their home or place of work.

Andrew Tucker (ETP project manager, Pharmacy2u) said that once the basic operation of ETP had been established, the consortium would be looking at providing additional services to patients using internet and mobile telephone technology. This could take the form of reminders to patients to take their medicines at specific times sent by e-mail or text messaging to mobile phones. The consortium was planning to transmit its first proper electronic prescription on September 1, Mr Tucker said, and about 150,000 would follow over the next 12 months.

The Transcript consortium is using a hybrid model, combining a “push” model for repeat prescriptions with barcoded forms for acute prescribing.

Martin Strange (operations director, Pharmed) said that the consortium had examined the relay model but found it difficult to implement efficiently and effectively, particularly as the pilot projects would have to use the NHSnet.

Since repeat prescribing made up about 60 per cent of all prescriptions, the consortium was replicating existing prescription collection services with its model. This had already been trialled in London two years ago.

Ian Shepherd (group head of information management and strategy, Royal Pharmaceutical Society) said that it was encouraging that a full range of solutions was to be trialled during the pilots. The Society had always supported models for ETP that were based on protecting patients' freedom of choice without any predetermination of where any particular prescription was dispensed.

He hoped that the evaluation of the three models would provide reliable information on the most appropriate composite model for a full national roll out, together with information on how patients used pharmacy services and different options for them under ETP.
Comment, p447

Pushing or pulling: electronic transfer of prescriptions in action

The initial aim of all three consortia is to replicate the existing prescription system (GP writes prescription, patient takes it to pharmacy, pharmacy dispenses it and sends it to the Prescription Pricing Authority for payment) in an electronic form. Once this has been achieved, other uses of ETP, including repeat dispensing and medicines management schemes, might be examined.

Sema

  • Members Sema, Boots the Chemists, National Co-operative Chemists, Cable & Wireless, Microsoft
  • Model Relay or pull model with prescriptions sent by GPs to a central server and then downloaded when the patient goes to a pharmacy. Copies sent to the PPA
  • Area North and South Peterborough Primary Care Trusts
  • Claimed advantages Little change for GPs. Allows freedom of choice for patients. System allows feedback so could be used for medicines management or repeat dispensing

Pharmacy2u

  • Members Pharmacy2u, 93 GPs, 133 pharmacies (including 123 North West Co-operative), Health Global Worldwide, RSA Security, Hadley Healthcare, academics from King's College London and University of Leeds
  • Model Push model with prescriptions sent directly from GPs to nominated pharmacies. Prescriptions can also be dispensed through the Pharmacy2u internet operation
  • Area Stockport and north London
  • Claimed advantages Patients can have home delivery of prescriptions and order repeats via internet

Transcript

  • Members Gehe UK (AAH Pharmaceuticals, Lloyds Pharmacy, Pharmed), Phoenix Medical Supplies, UniChem, British Telecommunications
  • Model Hybrid. Uses push model for repeat prescriptions sent directly to nominated pharmacies. Acute prescriptions have barcodes with prescription data and digital signature
  • Area To be decided. In discussion with several PCTs and health authorities
  • Claimed advantages Pharmed already has experience with ETP trials. Paper prescriptions provide fall back in case of technology failure

Back to Top



Jonathan Buisson is on the staff of The Pharmaceutical Journal



©The Pharmaceutical Journal